Immunotherapy, a relatively new type of cancer treatment, harnesses the power of your immune system to fight the cancer. It may be an option for advanced lung cancer depending on the characteristics of the tumor and how it interacts with your immune system.
In general, this type of therapy encourages your immune system’s white blood cells to fight the cancer directly. Dr. Kenneth Miller, Director of Outpatient Oncology at the University of Maryland Greenebaum Cancer Center, says that immunotherapy works for between 25% to 35% percent of people with advanced lung cancer.
Learn more about SurvivorNet's rigorous medical review process.
Dr. Ken Miller is Director of Outpatient Oncology at the University of Maryland, Greenebaum Cancer Center, and a member of the Thoracic Oncology Group. Read More
Immunotherapy, a relatively new type of cancer treatment, harnesses the power of your immune system to fight the cancer. It may be an option for advanced lung cancer depending on the characteristics of the tumor and how it interacts with your immune system.
In general, this type of therapy encourages your immune system’s white blood cells to fight the cancer directly. Dr. Kenneth Miller, Director of Outpatient Oncology at the University of Maryland Greenebaum Cancer Center, says that immunotherapy works for between 25% to 35% percent of people with advanced lung cancer.
Read More
